curasan Receives FDA Clearance for CERASORB Ortho FOAM

curasan received FDA 510(k) clearance to market CERASORB Ortho FOAM synthetic bone material. The resorbable ceramic and porcine collagen-based product is cleared for the treatment of bone defects in the extremities and pelvis.

In 2Q16, the company announced its planned investment in expansion of sales and marketing activities in the U.S. and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us